Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-22-018845
Filing Date
2022-07-12
Accepted
2022-07-12 16:01:22
Documents
6
Effectiveness Date
2022-07-12

Document Format Files

Seq Description Document Type Size
1 S-8 crdfs-8071222.htm S-8 65295
2 EX-FILING FEES ex-filingfees071222.htm EX-FILING FEES 18643
3 EX-5.1 a51ex071222.htm EX-5.1 10447
4 EX-23.2 a232ex071222.htm EX-23.2 2623
5 image_0.jpg GRAPHIC 125668
6 image_1.jpg GRAPHIC 195104
  Complete submission text file 0001628280-22-018845.txt   539365
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266103 | Film No.: 221079211
SIC: 2836 Biological Products, (No Diagnostic Substances)